0000000000252867

AUTHOR

Christian Seitz

showing 4 related works from this author

Treatment of Bladder Stones in Adults and Children: A Systematic Review and Meta-analysis on Behalf of the European Association of Urology Urolithias…

2019

Bladder stones (BS) constitute 5% of urinary stones. Currently, there is no systematic review of their treatment.To assess the efficacy (primary outcome: stone-free rate [SFR]) and morbidity of BS treatments.This systematic review was conducted in accordance with the European Association of Urology Guidelines Office. Database searches (1970-2019) were screened, abstracted, and assessed for risk of bias for comparative randomised controlled trials (RCTs) and nonrandomised studies (NRSs) with ≥10 patients per group. Quality of evidence (QoE) was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool.A total of 2742 abstracts and 59 full-text article…

Adultmedicine.medical_specialtyPercutaneousUrologymedia_common.quotation_subject030232 urology & nephrologyUrologyContext (language use)law.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawLithotripsyUreteroscopymedicineHumansChildSocieties Medicalmedia_commonUrinary Bladder Calculibusiness.industryConvalescenceGuidelinemedicine.diseaseEurope030220 oncology & carcinogenesisMeta-analysisRelative riskPractice Guidelines as TopicBladder stonesbusinessEuropean Urology
researchProduct

Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases

2021

Simple Summary Metastatic disease remains one of the biggest challenges for tumor therapy. The aim of our study was the preclinical evaluation of adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cell efficacy as a possible treatment strategy for various types of bone metastatic cancers. We confirmed that AdCAR NK-92 cells successfully induces tumor cell lysis in bone metastasis cell lines derived from mammary, renal cell and colorectal carcinoma as well as melanoma in a specific and controllable manner, thus, establishing a potent cellular product with universal applicability and quick clinical translation potential for the treatment of solid tumors, including metastases. Abstract…

0301 basic medicineCancer Researchmedicine.medical_treatmentlcsh:RC254-282ArticleTargeted therapy03 medical and health sciences0302 clinical medicineAntigenNK-92In vivomedicineCytotoxic T celladapterCytotoxicityNK-92bone metastasischimeric antigen receptorbusiness.industryBone metastasissolid tumorsmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensChimeric antigen receptor030104 developmental biologyOncology030220 oncology & carcinogenesisCancer researchbusinessCancers
researchProduct

Rare Tumors in Children and Adolescents - the STEP Working Group's Evolution to a Prospective Registry.

2021

Background Very rare tumors (VRT) in children and adolescents have such a low incidence that until recently, they have not been integrated into the clinical and scientific network of pediatric oncology. Data is very limited and consistent treatment strategies are missing. Thus, VRTs are classic orphan diseases. To counteract this problem, the Arbeitsgemeinschaft für Seltene Tumorerkrankungen in der Pädiatrie (STEP) was founded. Here we report on patient recruitment during the first 10 years. Patients Patients aged up to 18 years and not included in any other clinical trial or GPOH registry were included in this analysis. Methods Data was collected from 2008 to 2018 by means of a standardize…

Clinical consultationPediatricsmedicine.medical_specialtyAdolescentbusiness.industryIncidence (epidemiology)IncidenceOrphan diseasesMedical OncologyClinical trialPatient recruitmentRare DiseasesMISCELLANEOUS TUMORSNeoplasmsPediatrics Perinatology and Child HealthPediatric oncologyMedicineHumansRegistriesMedical diagnosisbusinessChildAgedKlinische Padiatrie
researchProduct

Imaging modalities and treatment of paediatric upper tract urolithiasis: A systematic review and update on behalf of the EAU urolithiasis guidelines …

2020

Prompt diagnosis and treatment of paediatric urolithiasis are required to avoid long term sequelae of renal damage.To systematically review the literature regarding the diagnostic imaging modalities and treatment approaches for paediatric urolithiasis.PubMed, Science Direct, Scopus and Web of Science were systematically searched from January 1980-January 2019. 76 full-text articles were included.Ultrasound and Kidney-Ureter-Bladder radiography are the baseline diagnostic examinations. Non-contrast Computed Tomography (CT) is the second line choice with high sensitivity (97-100%) and specificity (96-100%). Magnetic Resonance Urography accounts only for 2% of pediatric stone imaging studies. …

medicine.medical_specialtyUreteral CalculiUrologyRadiography030232 urology & nephrologyAsymptomatic03 medical and health sciencesKidney Calculi0302 clinical medicineUrolithiasis030225 pediatricsLithotripsyMedical imagingUreteroscopyMedicineHumansChildModalitiesmedicine.diagnostic_testbusiness.industryUltrasoundMagnetic resonance imagingTreatment OutcomeUpper tractPediatrics Perinatology and Child HealthPractice Guidelines as TopicRadiologymedicine.symptombusinessPyelogramJournal of pediatric urology
researchProduct